https://cav22inhibitor.com/int....egrability-associate
Kaplan-Meier 10 years survival prices had been 32.3%, 44.8% and 72.5% in T1, T2 and T3 of GNRI and 60.9%, 49.2% and 23.5per cent in T1, T2 and T3 of CRP, respectively (p0.0001 in both). Declined GNRI (HR 2.40, 95% CI 1.58 to 3.74, p0.0001 for T1 vs T3) and elevated CRP (HR 2.31, 95% CI 1.58 to 3.43, p0.0001 for T3 vs T1) had been defined as separate predictors of mortality. In connected setting of both variables, chance of death had been 5.55 times higher
Like
Comment
Share
